{"disease":{"id":"fragile-x-syndrome","name":"fragile x syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT05295277","title":"Validation of Optical Genome Mapping for the Identification of Constitutional Genomic Variants in a Postnatal Cohort","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Bionano Genomics","has_results":false},{"nct_id":"NCT03802799","title":"Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS","phase":"PHASE2, PHASE3","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":550,"lead_sponsor_name":"Zynerba Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT05367960","title":"An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":314,"lead_sponsor_name":"Tetra Discovery Partners","has_results":false},{"nct_id":"NCT07439510","title":"A Study to Investigate the Effects and Safety of SPG601 for the Treatment of Fragile X Syndrome in Male Participants","phase":"PHASE2, PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":248,"lead_sponsor_name":"Spinogenix","has_results":false},{"nct_id":"NCT04977986","title":"Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults With Fragile X Syndrome","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":215,"lead_sponsor_name":"Zynerba Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT03614663","title":"Clinical Study Of caNNabidiol in childrEn and adolesCenTs With Fragile X (CONNECT-FX)","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":212,"lead_sponsor_name":"Zynerba Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT06227780","title":"Alpha Auditory Entrainment for Cognitive Enhancement and Sensory Hypersensitivity in Youth With Developmental Disorders","phase":"NA","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":false},{"nct_id":"NCT05358886","title":"A Study of BPN14770 in Male Adults (Aged 18 to 45) With Fragile X Syndrome","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":171,"lead_sponsor_name":"Tetra Discovery Partners","has_results":false},{"nct_id":"NCT05163808","title":"A Randomized Study of BPN14770 in Male Adolescents (Aged 9 to < 18 Years) With Fragile X Syndrome","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":163,"lead_sponsor_name":"Tetra Discovery Partners","has_results":false},{"nct_id":"NCT02465931","title":"Decisional Capacity and Informed Consent in Fragile X Syndrome","phase":"NA","overall_status":"COMPLETED","enrollment_count":152,"lead_sponsor_name":"RTI International","has_results":true},{"nct_id":"NCT00362843","title":"Protein Synthesis in the Brain of Patients With Fragile X Syndrome","phase":"","overall_status":"COMPLETED","enrollment_count":147,"lead_sponsor_name":"National Institute of Mental Health (NIMH)","has_results":false},{"nct_id":"NCT03862950","title":"A Trial of Metformin in Individuals With Fragile X Syndrome (Met)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":125,"lead_sponsor_name":"University of Alberta","has_results":false},{"nct_id":"NCT03836300","title":"Parent and Infant Inter(X)Action Intervention (PIXI)","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":120,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT03479476","title":"A Trial of Metformin in Individuals With Fragile X Syndrome","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"University of California, Davis","has_results":false},{"nct_id":"NCT02920892","title":"AFQ056 for Language Learning in Children With FXS","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"Elizabeth Berry-Kravis","has_results":true},{"nct_id":"NCT07493096","title":"Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Healing Hope International","has_results":false},{"nct_id":"NCT02769949","title":"Pediatric Patients With Metabolic or Other Genetic Disorders","phase":"","overall_status":"COMPLETED","enrollment_count":96,"lead_sponsor_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","has_results":false},{"nct_id":"NCT05957549","title":"Tracking Early Emergence of Sound Perception Impairments in FXS With Multimodal fNIRS/EEG-Preschool Age","phase":"NA","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":false},{"nct_id":"NCT06480968","title":"CTH120 First-in-Human Study: Single and Multiple Ascending Doses and Potential Food Interaction","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":76,"lead_sponsor_name":"Connecta Therapeutics, S.L.","has_results":false},{"nct_id":"NCT03624556","title":"Pediatric Exploratory Research Study of EGCG Use and Safety (PERSEUS)","phase":"NA","overall_status":"COMPLETED","enrollment_count":76,"lead_sponsor_name":"Parc de Salut Mar","has_results":false},{"nct_id":"NCT05301361","title":"Sensitivity of the NIH Toolbox to Stimulant Treatment in Intellectual Disabilities","phase":"PHASE1","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":68,"lead_sponsor_name":"University of California, Davis","has_results":false},{"nct_id":"NCT06088589","title":"Speech-in-noise Perception in Autism and Fragile X","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":false},{"nct_id":"NCT06261450","title":"Effect of CBD on the Brain","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":50,"lead_sponsor_name":"Université de Sherbrooke","has_results":false},{"nct_id":"NCT01911455","title":"Study of Acamprosate in Fragile x Syndrome","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":false},{"nct_id":"NCT05418049","title":"Evaluating the Neurophysiologic and Clinical Effects of Single Dose Drug Challenge","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":45,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":false},{"nct_id":"NCT01855971","title":"\"Using Epigallocatechin Gallate (EGCG) and Cognitive Training to Modulate Cognitive Performance in Patients With Fragile X Syndrome\" (TESFX)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Parc de Salut Mar","has_results":false},{"nct_id":"NCT06293027","title":"Optical Imaging as a Tool for Monitoring Brain Function in Fragile X Syndrome","phase":"","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"IRCCS Fondazione Stella Maris","has_results":false},{"nct_id":"NCT06261502","title":"Effect of CANnabidiol on Anxiety and GABAergic Function in Individuals with Fragile-X Syndrome","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Université de Sherbrooke","has_results":false},{"nct_id":"NCT04698551","title":"NIPD on cffDNA for Triplet Repeat Diseases","phase":"","overall_status":"UNKNOWN","enrollment_count":36,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT03697161","title":"A Study of OV101 in Individuals With Fragile X Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Healx AI","has_results":true},{"nct_id":"NCT06560242","title":"Tracking Early Emergence of Sound Perception Impairments in FXS With Multimodal fNIRS/EEG- Infant","phase":"NA","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":false},{"nct_id":"NCT03569631","title":"A 2-Period Crossover Study of BPN14770 in Adults Males With Fragile X Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Tetra Discovery Partners","has_results":true},{"nct_id":"NCT06957054","title":"Neural Biomarkers in Fragile X Syndrome","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Connecta Therapeutics, S.L.","has_results":false},{"nct_id":"NCT05120505","title":"Metformin in Children With Fragile X Syndrome","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Children's Hospital of Fudan University","has_results":false},{"nct_id":"NCT06677866","title":"Group CBT in Adolescents With Fragile X Syndrome and in Adolescents With Autism Spectrum Disorder","phase":"NA","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Bambino Gesù Hospital and Research Institute","has_results":false},{"nct_id":"NCT04308954","title":"Neuroimaging GABA Physiology in Fragile X Syndrome","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":17,"lead_sponsor_name":"Stanford University","has_results":false},{"nct_id":"NCT06279858","title":"Probiotic Intervention for Microbiome Modifications and Clinical Improvements in Fragile X Syndrome","phase":"NA","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"Specila hospital for cerebral palsy and developmental neurology","has_results":false},{"nct_id":"NCT05030129","title":"ERG/5-HTP in Fragile X Syndrome (FXS)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Elizabeth Berry-Kravis","has_results":true},{"nct_id":"NCT05233579","title":"Open-Label Trial of Sulforaphane in Premutation Carriers With FXTAS","phase":"NA","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"University of California, Davis","has_results":false},{"nct_id":"NCT03140813","title":"An Initial Study of AZD7325 in Adults With Fragile X Syndrome","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":false},{"nct_id":"NCT03722290","title":"Metformin in Children and Adults With Fragile X Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Université de Sherbrooke","has_results":false},{"nct_id":"NCT03109756","title":"Single Dose Pharmacokinetic (PK) Study","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Healx AI","has_results":false},{"nct_id":"NCT06413537","title":"Study of SPG601 in Adult Men With Fragile X Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Spinogenix","has_results":false},{"nct_id":"NCT06334419","title":"Placebo-Controlled, Single-Dose Challenge Study of Gaboxadol in Adult Males With Fragile X Syndrome (FXS)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Craig Erickson","has_results":false},{"nct_id":"NCT01187524","title":"The Natural History of Reproductive and Overall Health in Girls and Women With a Pre-Mutation in the FMR1 Gene; Creation of a Patient Registry","phase":"","overall_status":"TERMINATED","enrollment_count":7,"lead_sponsor_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","has_results":false},{"nct_id":"NCT04428567","title":"Treadmill Training in Fragile X-associated Tremor/Ataxia Syndrome","phase":"NA","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"Rush University Medical Center","has_results":false},{"nct_id":"NCT04823052","title":"Investigation of Sulindac (HLX-0201) and Gaboxadol (HLX-0206) in Male Fragile X Syndrome Patients Aged 13-40","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Healx Limited","has_results":false}],"total":48},"guidelines":[],"source":"Drug Landscape verified database"}